Incannex Healthcare (IXHL) Receivables - Other (2021 - 2026)
Incannex Healthcare (IXHL) posted quarterly Receivables - Other of $5.2 million for Q1 2026, down 26.25% year-on-year from $7.1 million in Q1 2025, and up 3.68% on a QoQ basis from $5.1 million in Q4 2025.
Incannex Healthcare (IXHL) Receivables - Other (2021 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Receivables - Other for 4 consecutive years, with $5.2 million the latest figure, recorded in Q1 2026.
- Quarterly Receivables - Other fell 26.25% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 26.25% YoY) and the FY2025 annual result came in at $4.1 million, down 58.0% from the prior year.
- Receivables - Other climbed to $5.2 million in Q1 2026 per IXHL's latest filing, from $5.1 million in the prior quarter.
- Over the last five years, Receivables - Other for IXHL reached as high as $11.1 million in Q3 2024 and fell as low as $4.1 million in Q2 2025.
- A 3-year average of $6.7 million and a median of $5.9 million in 2024 frame the typical range for Receivables - Other.
- The largest YoY upside for Receivables - Other was 23.49% in 2025 against a maximum downside of 59.17% in 2025.
- Year by year, Receivables - Other stood at $6.6 million in 2024, then decreased by 23.49% to $5.1 million in 2025, then advanced by 3.68% to $5.2 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $5.2 million, $5.1 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.05 Mn |
| Dec 31, 2025 | 5.05 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Dec 31, 2024 | 6.61 Mn |
| Dec 31, 2024 | 6.61 Mn |
| Sep 30, 2024 | 11.09 Mn |
| Sep 30, 2024 | 11.09 Mn |
| Jun 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 9.84 Mn |
| Jun 30, 2021 | 53,447.00 |
| Jun 30, 2021 | 53,447.00 |